Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Barton Kenney, Arthur Zieske, Henry Rinder & Brian Smith. (2008) DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia. Leukemia & Lymphoma 49:1, pages 42-48.
Read now
Read now
Michael N. Dworzak & Eva R. Panzer-Grümayer. (2003) Flow Cytometric Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia. Leukemia & Lymphoma 44:9, pages 1445-1455.
Read now
Read now
Articles from other publishers (18)
Laura Wake, Xueyan Chen & Michael J. Borowitz. 2019. Minimal Residual Disease Testing. Minimal Residual Disease Testing
23
68
.
Michael Keeney, Brent L. Wood, Benjamin D. Hedley, Joseph A. DiGiuseppe, Maryalice Stetler-Stevenson, Elisabeth Paietta, Gerard Lozanski, Adam C. Seegmiller, Bruce W. Greig, Aaron C. Shaver, Lata Mukundan, Howard R. Higley, Caroline C. Sigman, Gary Kelloff, J. Milburn Jessup & Michael J. Borowitz. (2018) A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters. Cytometry Part B: Clinical Cytometry 94:2, pages 239-249.
Crossref
Crossref
Katayoon Jafari, Anne Tierens, Amr Rajab, Rumina Musani, André Schuh & Anna Porwit. (2018) Visualization of Cell Composition and Maturation in the Bone Marrow Using 10-Color Flow Cytometry and Radar Plots. Cytometry Part B: Clinical Cytometry 94:2, pages 219-229.
Crossref
Crossref
Prashant R. Tembhare, Sitaram Ghogale, Nisha Ghatwai, Yajamanam Badrinath, Nikesh Kunder, Nikhil V. Patkar, Asma R. Bibi, Gaurav Chatterjee, Brijesh Arora, Gaurav Narula, Shripad Banawali, Nilesh Deshpande, Prathibha Amare, Sumeet Gujral & Papagudi G. Subramanian. (2016) Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000. Cytometry Part B: Clinical Cytometry 94:1, pages 100-111.
Crossref
Crossref
Michael J. BorowitzBrent L. WoodMeenakshi DevidasMignon L. LohElizabeth A. RaetzWanda L. SalzerJames B. NachmanAndrew J. CarrollNyla A. HeeremaJulie M. Gastier-FosterCheryl L. WillmanYunfeng DaiNaomi J. WinickStephen P. HungerWilliam L. Carroll & Eric Larsen. (2015) Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232. Blood 126:8, pages 964-971.
Crossref
Crossref
Michael J. Borowitz. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
211
218.e2
.
Patrick A. Zweidler-McKay & Michael J. Borowitz. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
45
60
.
Nicolaus Kr?ger, Ulrike Bacher, Peter Bader, Sebastian B?ttcher, Michael J. Borowitz, Peter Dreger, Issa Khouri, Homer Macapintac, Eduardo Olavarria, Jerald Radich, Wendy Stock, Julie M. Vose, Daniel Weisdorf, Andre Willasch, Sergio Giralt, Michael R. Bishop & Alan S. Wayne. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, Acute Leukemias, and Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation 16:9, pages 1187-1211.
Crossref
Crossref
Michael J. BorowitzMeenakshi DevidasStephen P. HungerW. Paul BowmanAndrew J. CarrollWilliam L. CarrollStephen LindaPaul L. MartinD. Jeanette PullenDavid ViswanathaCheryl L. WillmanNaomi WinickBruce M. Camitta. (2008) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 111:12, pages 5477-5485.
Crossref
Crossref
Gunter Kerst, Nina Bergold, Friederike Gieseke, Elaine Coustan-Smith, Peter Lang, Marketa Kalinova, Rupert Handgretinger, Jan Trka & Ingo Müller. (2008) WT1 protein expression in childhood acute leukemia. American Journal of Hematology 83:5, pages 382-386.
Crossref
Crossref
Syed Abutalib & Wendy Stock. 2008. Acute Leukemias. Acute Leukemias
247
262
.
Gunter Kerst, Hermann Kreyenberg, Carmen Roth, Catrin Well, Klaus Dietz, Elaine Coustan-Smith, Dario Campana, Ewa Koscielniak, Charlotte Niemeyer, Paul G. Schlegel, Ingo Muller, Dietrich Niethammer & Peter Bader. (2005) Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR. British Journal of Haematology 128:6, pages 774-782.
Crossref
Crossref
M Malec, V H J van der Velden, E Björklund, J M Wijkhuijs, S Söderhäll, J Mazur, M Björkholm & A Porwit-MacDonald. (2004) Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping. Leukemia 18:10, pages 1630-1636.
Crossref
Crossref
Mar??a B Vidriales, Jes?s F San-Miguel, Alberto Orfao, Elaine Coustan-Smith & Dario Campana. (2003) Minimal residual disease monitoring by flow cytometry. Best Practice & Research Clinical Haematology 16:4, pages 599-612.
Crossref
Crossref
Mar?a-Bel?n Vidriales, Alberto Orfao & Jes?s F. San-Miguel. (2003) Immunologic monitoring in adults with acute lymphoblastic leukemia. Current Oncology Reports 5:5, pages 413-418.
Crossref
Crossref
Michael N. DworzakGertraud FröschlDieter PrintzGeorg MannUlrike PötschgerNora MühleggerGerhard FritschHelmut Gadner. (2002) Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood 99:6, pages 1952-1958.
Crossref
Crossref
Dario Campana & Elaine Coustan-Smith. (2002) Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia. Best Practice & Research Clinical Haematology 15:1, pages 1-19.
Crossref
Crossref
. (2000) Current Awareness. Hematological Oncology 18:4, pages 161-168.
Crossref
Crossref